Press Releases

Biocon Biologics  /  Press Releases

Biocon Q3FY19 Earnings Revenue at Rs 1,566 Cr, Up 43%; Net Profit at Rs 217 Cr, Up 136% EBITDA at Rs 406 Cr, Up 59%

  • Posted by: Biocon Biologics

Biocon Foundation Dedicates Rejuvenated Hebbagodi Lake and Children’s Park to the Community

  • Posted by: Biocon Biologics

Biocon Ranked 7th on Top Global Pharma & Biotech Employers List 2018

  • Posted by: Biocon Biologics

Biocon Q2FY19 Revenue at Rs 1,375 Cr, Up 35%; EBITDA at Rs 394 Cr, Up 69%; Net Profit at Rs 355 Cr; Net Profit (excluding exceptional income) at Rs 184 Cr; Up 167%

  • Posted by: Biocon Biologics

Biocon and Mylan Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

  • Posted by: Biocon Biologics

Biocon and Mylan Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim

  • Posted by: Biocon Biologics

Biocon Q1FY19 Revenue Rs 1,193 Cr, Up 21%; EBITDA Up 25% at Rs 307 Cr; Net Profit Up 47% at Rs 120 Cr

  • Posted by: Biocon Biologics

Kiran Mazumdar-Shaw Elected Full-Term Member of the Board of Trustees of MIT, USA

  • Posted by: Biocon Biologics

U.S. FDA Approves Mylan and Biocon’s Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®

  • Posted by: Biocon Biologics

Tata Memorial Hospital Team Presents Biocon’s Nimotuzumab Study Results at ASCO Annual Meeting 2018

  • Posted by: Biocon Biologics
Share
buy twitter followers - omegle - SOL sniper bot - marsbahis güncel giriş